Startseite Identification of two novel variants in GAA underlying infantile-onset Pompe disease in two Pakistani families
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Identification of two novel variants in GAA underlying infantile-onset Pompe disease in two Pakistani families

  • Aman Ullah ORCID logo , Bibi Zubaida , Huma Arshad Cheema und Muhammad Naeem ORCID logo EMAIL logo
Veröffentlicht/Copyright: 12. Februar 2020

Abstract

Background

Pompe disease (PD) is an autosomal recessive metabolic myopathy with an average incidence of one in 40,000 live births. It has a variable age of onset and can be diagnosed within the first 3 months. Heart involvement and muscle weakness are its primary manifestations.

Case presentation

We describe two families affected by PD with two rare, novel variants. To date, pathogenic variants in acid α-glucosidase (GAA) alone have accounted for all cases of the disease. Both families were screened for pathogenic sequence variations. This study presents the implications of regulatory or modifier sequences in the disease pathogenesis for the first time. A homozygous missense p.Arg854Gln variant in family A and a single heterozygous variant (p.Asn925His) in family B were found to be segregating according to the disease phenotype. The variants were not detected in our in-house database comprising 50 whole-exome sequences of healthy individuals from a local unrelated Pakistani population. In silico analyses predicted that the variants would have deleterious effects on the protein structure.

Conclusions

The variants likely underlie the infantile-onset PD (IOPD) in these Pakistani families. The study expands the mutation spectrum of GAA associated with IOPD and highlights the insufficiency of screening the GAA coding sequence to determine the cause of IOPD. The work should be helpful in carrier identification, improving genetic counselling, and prenatal diagnosis.


Corresponding author: Muhammad Naeem, PhD, Medical Genetics Research Laboratory, Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan, Phone: +925190644122, Cell: +92-333-5324922

Acknowledgements

Aman Ullah was supported by the Higher Education Commission of Pakistan through the Indigenous PhD Fellowship (PIN: 213-56956-2BM2-133).

  1. Author contributions: All of the authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Marco S, Veronica P, Federica R, Elisa B, Tiziana M, et al. Early higher dosage of alglucosidase alpha in classic Pompe disease. J Pediatr Endocrinol Metab 2018;31:1–5.Suche in Google Scholar

2. Schoser B, Bilder DA, Dimmock D, Gupta D, James ES, et al. The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol 2017; 17:202.10.1186/s12883-017-0983-2Suche in Google Scholar PubMed PubMed Central

3. Fukuhara Y, Fuji N, Yamazaki N, Hirakiyama A, Kamioka T, et al. A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan. Mol Genet Metab Rep 2017;14:3–9.10.1016/j.ymgmr.2017.10.009Suche in Google Scholar PubMed PubMed Central

4. Miriam M, Mar GR, Luis GG, Marta C, Rita MR, et al. Infantile-onset Pompe disease with neonatal debut: a case report and literature review. Medicine (Baltimore) 2017;96:e9186.10.1097/MD.0000000000009186Suche in Google Scholar PubMed PubMed Central

5. Amarinthnukrowh P, Tongkobpetch S, Kongpatanayothin A, Suphapeetiporn K, Shotelersuk V. p.D645E of acid α-glucosidase is the most common mutation in Thai patients with infantile-onset Pompe disease. Genet Test Mol Biomarkers 2011;14:835–7.10.1089/gtmb.2010.0038Suche in Google Scholar PubMed

6. Mari M, Gloria H, Zoheb K, Xiaolin Z, Stephanie MD, et al. Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease. Mol Genet Metab 2017;122:189–97.10.1016/j.ymgme.2017.10.008Suche in Google Scholar PubMed PubMed Central

7. Cabello JF, Marsden D. Pompe disease: clinical perspectives. Orphan Drugs: Res. Rev 2016;7:1–10.Suche in Google Scholar

8. Wens SC, van Gelder CM, Kruijshaar ME, de Vries JM, van der Beek NA, et al. Phenotypical variation within 22 families with Pompe disease. Orphanet J Rare Dis 2013;8:182.10.1186/1750-1172-8-182Suche in Google Scholar PubMed PubMed Central

Received: 2019-10-13
Accepted: 2019-12-22
Published Online: 2020-02-12
Published in Print: 2020-04-28

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Prevalence of obesity and overweight in Iranian students: a systematic review and meta-analysis
  4. Original Articles
  5. Trends in pediatric obesity management, a survey from the Pediatric Endocrine Society Obesity Committee
  6. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents
  7. Vitamin D status and its relation to insulin resistance in a Mexican pediatric population
  8. Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China
  9. Is there a relationship between the dietary inflammatory index and metabolic syndrome among adolescents?
  10. New insights into the expression of androgen and estrogen receptors of the appendix testis in congenital cryptorchidism
  11. General properties of autoimmune thyroid diseases and associated morbidities
  12. Comparison of leptin levels in neonates born to mothers with high or low gestational weight gain
  13. Percentile values of serum zinc concentration and prevalence of its deficiency in Iranian children and adolescents: the CASPIAN-V study
  14. Nine-year overview of dyslipidemia management in children with heterozygous familial hypercholesterolemia: a university hospital outpatient lipid clinic project in Northwestern Greece
  15. Gesell Developmental Schedules scores and the relevant factors in children with Down syndrome
  16. Letters to the Editor
  17. Society for Pediatric Radiology (SPR) Child Abuse Committee response regarding Miller, Stolfi and Ayoub’s flawed theories about child abuse and metabolic bone disease
  18. Reply of Miller and Ayoub to Brown et al. Letter to the Editor
  19. Case Reports
  20. Identification of two novel variants in GAA underlying infantile-onset Pompe disease in two Pakistani families
  21. Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route
  22. Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS)
  23. Challenges in the management of an ignored cause of hyperammonemic encephalopathy: pyruvate carboxylase deficiency
  24. Autoimmune polyglandular syndrome type II with co-manifestation of Addison’s and Graves’ disease in a 15-year-old boy: case report and literature review
Heruntergeladen am 9.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0477/pdf
Button zum nach oben scrollen